Early Catheter-directed Treatment of High Risk Pulmonary Embolism
ConditionPulmonary Embolism Acute Massive
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLeipzig Heart Science gGmbH
About this trial
Prospective, multicenter, open label, randomized controlled clinical trial to compare the effects of an early catheter-directed treatment plus conventional care with conventional care in patients with high-risk pulmonary embolism
Eligibility criteria
Qualifiers
Age ≥18 years
Disqualifiers
Contraindications for catheter-based treatment
Contraindications to systemic fibrinolytic treatment or anticoagulation*
Active, potentially life-threatening bleeding
Surgery within 24h before screening
Trial design
Treatments tested in this trial
- Early Catheter-Interventional Treatment
- Conventional care
Treatment groups
210 Participants
are divided into 2 treatment groupsLocations
18Universitätsklinikum Freiburg79189, Bad Krozingen Germany
Oberlausitzklinikum Bautzen, Medizinische Klinik I02625, Bautzen Germany
Universitätsklinikum Bonn53127, Bonn Germany
Universitätsklinik Düsseldorf, Klinik für Kardiologie, Pneumologie und Angiologie40225, Düsseldorf Germany
Sponsors and collaborators
Leipzig Heart Science gGmbH
Lead sponsor
Heart Center Leipzig at University of Leipzig
Collaborator
Helios Health Institute GmbH
Collaborator
Source ClinicalTrials.gov